Cargando…

Post-ovulatory Hemoperitoneum in a Patient on Anticoagulation Therapy for Mitral Valve Replacement

When a patient is receiving anticoagulant therapy, the rupture of a corpus luteum cyst may go unrecognized in healthy women but becomes clinically relevant as it might exacerbate a hemoperitoneum episode. This report describes the case of a 26-year-old primipara who underwent surgical treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Muneeba, Shaikh, Acharya, Neema, Acharya, Sourya, Joshi, Ketav, Mohammad, Shazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918852/
https://www.ncbi.nlm.nih.gov/pubmed/36788926
http://dx.doi.org/10.7759/cureus.33674
_version_ 1784886678697017344
author Muneeba, Shaikh
Acharya, Neema
Acharya, Sourya
Joshi, Ketav
Mohammad, Shazia
author_facet Muneeba, Shaikh
Acharya, Neema
Acharya, Sourya
Joshi, Ketav
Mohammad, Shazia
author_sort Muneeba, Shaikh
collection PubMed
description When a patient is receiving anticoagulant therapy, the rupture of a corpus luteum cyst may go unrecognized in healthy women but becomes clinically relevant as it might exacerbate a hemoperitoneum episode. This report describes the case of a 26-year-old primipara who underwent surgical treatment for a heart defect and later experienced extensive hemoperitoneum. The patient reported to the casualty with symptoms of unstable hemodynamic status such as hypotension 90/60 mmHg and tachycardia 120 beats/minute. A multidisciplinary team decided upon surgical management after stabilizing the coagulation profile and correcting the shock with blood and blood products. The reason was discovered to be a ruptured cyst wall, which was fixed electrosurgically. The patient had a full recovery with no postoperative complications. The most noteworthy aspect of this case was the catastrophic hemoperitoneum caused by improper anticoagulant treatment monitoring. Management of such cases depends on the age of the patient, fertility, and calculating the long-term prognosis of the anticoagulation therapy for the patient.
format Online
Article
Text
id pubmed-9918852
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-99188522023-02-13 Post-ovulatory Hemoperitoneum in a Patient on Anticoagulation Therapy for Mitral Valve Replacement Muneeba, Shaikh Acharya, Neema Acharya, Sourya Joshi, Ketav Mohammad, Shazia Cureus Cardiology When a patient is receiving anticoagulant therapy, the rupture of a corpus luteum cyst may go unrecognized in healthy women but becomes clinically relevant as it might exacerbate a hemoperitoneum episode. This report describes the case of a 26-year-old primipara who underwent surgical treatment for a heart defect and later experienced extensive hemoperitoneum. The patient reported to the casualty with symptoms of unstable hemodynamic status such as hypotension 90/60 mmHg and tachycardia 120 beats/minute. A multidisciplinary team decided upon surgical management after stabilizing the coagulation profile and correcting the shock with blood and blood products. The reason was discovered to be a ruptured cyst wall, which was fixed electrosurgically. The patient had a full recovery with no postoperative complications. The most noteworthy aspect of this case was the catastrophic hemoperitoneum caused by improper anticoagulant treatment monitoring. Management of such cases depends on the age of the patient, fertility, and calculating the long-term prognosis of the anticoagulation therapy for the patient. Cureus 2023-01-12 /pmc/articles/PMC9918852/ /pubmed/36788926 http://dx.doi.org/10.7759/cureus.33674 Text en Copyright © 2023, Muneeba et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Muneeba, Shaikh
Acharya, Neema
Acharya, Sourya
Joshi, Ketav
Mohammad, Shazia
Post-ovulatory Hemoperitoneum in a Patient on Anticoagulation Therapy for Mitral Valve Replacement
title Post-ovulatory Hemoperitoneum in a Patient on Anticoagulation Therapy for Mitral Valve Replacement
title_full Post-ovulatory Hemoperitoneum in a Patient on Anticoagulation Therapy for Mitral Valve Replacement
title_fullStr Post-ovulatory Hemoperitoneum in a Patient on Anticoagulation Therapy for Mitral Valve Replacement
title_full_unstemmed Post-ovulatory Hemoperitoneum in a Patient on Anticoagulation Therapy for Mitral Valve Replacement
title_short Post-ovulatory Hemoperitoneum in a Patient on Anticoagulation Therapy for Mitral Valve Replacement
title_sort post-ovulatory hemoperitoneum in a patient on anticoagulation therapy for mitral valve replacement
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918852/
https://www.ncbi.nlm.nih.gov/pubmed/36788926
http://dx.doi.org/10.7759/cureus.33674
work_keys_str_mv AT muneebashaikh postovulatoryhemoperitoneuminapatientonanticoagulationtherapyformitralvalvereplacement
AT acharyaneema postovulatoryhemoperitoneuminapatientonanticoagulationtherapyformitralvalvereplacement
AT acharyasourya postovulatoryhemoperitoneuminapatientonanticoagulationtherapyformitralvalvereplacement
AT joshiketav postovulatoryhemoperitoneuminapatientonanticoagulationtherapyformitralvalvereplacement
AT mohammadshazia postovulatoryhemoperitoneuminapatientonanticoagulationtherapyformitralvalvereplacement